Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anus Neoplasms × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 27 Carcinoma, Transitional Cell 22 Urinary Bladder Neoplasms 21 Neoplasms 20 Carcinoma, Merkel Cell 19 Neoplasm Metastasis 17 Colorectal Neoplasms 15 Carcinoma, Renal Cell 15 Breast Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 12 Ovarian Neoplasms 12 Triple Negative Breast Neoplasms 8 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Stomach Neoplasms 6 Melanoma 6 Recurrence 5 Prostatic Neoplasms 5 Carcinoma, Hepatocellular 5 Ureteral Neoplasms 4 Small Cell Lung Carcinoma 4 Neuroendocrine Tumors 4 Glioblastoma 4 Carcinoma, Squamous Cell 4 Uterine Cervical Neoplasms 3 Urethral Neoplasms 3 Turcot syndrome 3 Skin Neoplasms 3 Sarcoma 3 Lymphoma 3

Interventions

Fluorouracil 23 Mitomycin 16 Radiotherapy 14 Capecitabine 12 Cisplatin 11 pembrolizumab 9 Cyclophosphamide 8 Radiation 7 fludarabine 6 Specimen Handling 6 Paclitaxel 6 Nivolumab 6 Magnetic Resonance Spectroscopy 6 Biopsy 6 Cetuximab 5 Carboplatin 5 dehydroftorafur 4 Vaccines 4 Papillomavirus Vaccines 4 Irinotecan 4 Drug Therapy 4 aldesleukin 3 Watchful Waiting 3 Radiotherapy, Intensity-Modulated 3 Oxaliplatin 3 Observation 3 Light Coagulation 3 Ipilimumab 3 Interleukin-2 3 Fluorodeoxyglucose F18 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03944252 2019-07-26

CARACAS

Gruppo Oncologico del Nord-Ovest

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡